GlassScriptPhysician profile
Mitchell Nicholas Rashid
NPI 1689771149
$12,423.25
in general payments reported to CMS, 2019-2025
20 companies · $2,420 in 2025
The $2,420 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $261 · 2021: $344 · 2022: $1,972 · 2023: $3,379 · 2024: $2,878 · 2025: $2,420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,998 · Travel and Lodging: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,997.57 |
| Travel and Lodging | $679.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $3,365.45 | 2022-2025 | Assure Wcd |
| Boston Scientific Corporation | $2,551.15 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Rotapro |
| Shockwave Medical, INC | $2,151.87 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $956.66 | 2019-2024 | Diamondback Coronary, Aveir |
| Biotronik INC. | $823.36 | 2019-2023 | Orsiro Mission |
| Medtronic, INC. | $466.89 | 2021-2024 | Linq II, Reveal Linq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $366.56 | 2019-2025 | Lifevest |
| Recor Medical INC | $307.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cvrx, INC. | $230.62 | 2024-2025 | Barostim Neo System |
| Heartflow, INC. | $221.15 | 2022-2023 | Ffrct |
| Janssen Pharmaceuticals, INC | $150.85 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $144.30 | 2020-2025 | |
| Teleflex LLC | $138.83 | 2025 | Orsiro Mission |
| Abiomed | $135.65 | 2024-2025 | Impella |
| Cardiovascular Systems INC. | $109.01 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $100.99 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Penumbra, INC. | $91.06 | 2025 | Penumbra System |
| Terumo Medical Corporation | $64.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.79 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $20.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Rashid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.